Expert Rev Pharmacoecon Outcomes Res
December 2018
Introduction: The emergence of immune-modulating drugs such as biologics has altered the treatment landscape for psoriasis. However, their use presents high financial costs to patients and healthcare systems. Patient demographic and socioeconomic status may influence adherence to biologic medications and usage of healthcare resources.
View Article and Find Full Text PDF